Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Alesi Surgical
company
About
Alesi Surgical develops and commercialises products that improve the safety
- 11 - 50
Highlights
Details
- Last Funding Type
- Grant
- Industries
- Biotechnology,Health Care,Therapeutics
- Founded date
- Jan 1, 2009
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Alesi Surgical was founded in 2009 to develop and commercialise products that improve the safety, efficacy and outcomes of surgical procedures. The company is a spin-out from the Welsh Institute for Minimal Access Therapy (WIMAT), a leading surgical training centre in the UK. Alesi Surgical has a unique level of access to experienced surgeons, surgical trainers and trainees, which allows it to identify issues in procedures and design devices to address these issues.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
—
Alesi Surgical has raised a total of
—
in funding over 2 rounds. Their latest funding was raised on
Dec 19, 2022 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 19, 2022 | Grant | — | 1 |
European Innovation Council
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Alesi Surgical is funded by 1 investors.
European Innovation Council
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
European Innovation Council
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
